Stockreport

CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML [Yahoo! Finance]

CERo Therapeutics Holdings, Inc.  (CERO) 
PDF Company issues correction of recently published article, asserts it is not for sale and is not currently actively seeking partnerships as it continues dose finding clin [Read more]